News & Updates

Probiotics supplementation offers no help in functional constipation

13 Oct 2024

In healthy individuals with functional constipation, probiotics supplementation does not appear to increase bowel movement frequency as compared with placebo, according to a study.

Probiotics supplementation offers no help in functional constipation

13 Oct 2024

TYK2 inhibitor looks good for lichen planopilaris

13 Oct 2024 by

Deucravacitinib, an oral selective inhibitor of tyrosine kinase 2 (TYK2), shows promise in the treatment of lichen planopilaris (LPP), with substantial reductions in disease activity, according to the interim analysis of an open-label, single-arm trial.

TYK2 inhibitor looks good for lichen planopilaris

13 Oct 2024

RFM helps spot adults with high body fat percentage

13 Oct 2024

Relative fat mass (RFM) accurately identifies people with an elevated body fat percentage (BF%), but it is not as accurate as dual energy x-ray absorptiometry (DXA) in estimating BF%, reports a Chile study.

RFM helps spot adults with high body fat percentage

13 Oct 2024

Lithium aspartate of no benefit in post-COVID fatigue, cognitive dysfunction

13 Oct 2024

Treatment with lithium aspartate yields no significant effect on long COVID symptoms of fatigue and cognitive dysfunction, as shown in a study.

Lithium aspartate of no benefit in post-COVID fatigue, cognitive dysfunction

13 Oct 2024

Upadacitinib superior to dupilumab in patients with moderate-to-severe AD

13 Oct 2024 by

Treatment with upadacitinib demonstrated superior efficacy in achieving near-complete skin clearance and little to no itch at 16 weeks compared with dupilumab among adolescents and adults with moderate-to-severe atopic dermatitis (AD), according to the LEVEL UP study presented at EADV 2024.

Upadacitinib superior to dupilumab in patients with moderate-to-severe AD

13 Oct 2024

No evidence of association between smoking and intracranial aneurysm growth

12 Oct 2024

Smoking does not appear to carry an excess risk of the growth of intracranial aneurysms, according to the results of a meta-analysis.

No evidence of association between smoking and intracranial aneurysm growth

12 Oct 2024

Hidradenitis suppurativa patients get durable benefit with bimekizumab

12 Oct 2024 by

The interleukin-17 blocker bimekizumab delivers sustained clinical benefits lasting up to 2 years for patients with moderate-to-severe hidradenitis suppurativa, as reported in a late-breaking presentation at EADV 2024.

Hidradenitis suppurativa patients get durable benefit with bimekizumab

12 Oct 2024

Risankizumab eases symptoms in nonpustular palmoplantar psoriasis

12 Oct 2024 by

In patients with nonpustular palmoplantar psoriasis (nPPP), treatment with risankizumab relieves disease symptoms, such as skin pain in palms or soles of feet, by week 16, as shown by the results of a post hoc analysis of the phase IIIb IMMprint study. These improvements persist up to week 52.

Risankizumab eases symptoms in nonpustular palmoplantar psoriasis

12 Oct 2024

Tranexamic acid use during open radical cystectomy for bladder cancer of no benefit

12 Oct 2024

Treatment with tranexamic acid does not appear to reduce blood transfusion in patients during open radical cystectomy for bladder cancer, as shown in the results of the Tranexamic Acid During Cystectomy Trial (TACT).

Tranexamic acid use during open radical cystectomy for bladder cancer of no benefit

12 Oct 2024

As-needed ruxolitinib in children with AD: Disease control stable through 52 weeks

12 Oct 2024 by

As-needed application of ruxolitinib cream, a topically administered selective Janus kinase 1/2 inhibitor, resulted in long-term safety and disease control in children aged 2–11 years with mild-to-moderate atopic dermatitis (AD), according to updated results of the phase III TRuE-AD3 trial presented at EADV 2024.

As-needed ruxolitinib in children with AD: Disease control stable through 52 weeks

12 Oct 2024

News & Updates

Filter by Specialty:

Specialty:

Probiotics supplementation offers no help in functional constipation

Probiotics supplementation offers no help in functional constipation

TYK2 inhibitor looks good for lichen planopilaris

TYK2 inhibitor looks good for lichen planopilaris

RFM helps spot adults with high body fat percentage

RFM helps spot adults with high body fat percentage

Lithium aspartate of no benefit in post-COVID fatigue, cognitive dysfunction

Lithium aspartate of no benefit in post-COVID fatigue, cognitive dysfunction

Upadacitinib superior to dupilumab in patients with moderate-to-severe AD

Upadacitinib superior to dupilumab in patients with moderate-to-severe AD

No evidence of association between smoking and intracranial aneurysm growth

No evidence of association between smoking and intracranial aneurysm growth

Hidradenitis suppurativa patients get durable benefit with bimekizumab

Hidradenitis suppurativa patients get durable benefit with bimekizumab

Risankizumab eases symptoms in nonpustular palmoplantar psoriasis

Risankizumab eases symptoms in nonpustular palmoplantar psoriasis

Tranexamic acid use during open radical cystectomy for bladder cancer of no benefit

Tranexamic acid use during open radical cystectomy for bladder cancer of no benefit

As-needed ruxolitinib in children with AD: Disease control stable through 52 weeks

As-needed ruxolitinib in children with AD: Disease control stable through 52 weeks